Yahoo
OTC Markets OTCPK - Delayed Quote USD

Isodiol International Inc. (ISOLF)

0.0001 0.0000 (0.00%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for ISOLF
  • Previous Close 0.0001
  • Open 0.0001
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0001
  • Volume 500
  • Avg. Volume 0
  • Market Cap (intraday) 4,913
  • Beta (5Y Monthly) -194.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Isodiol International Inc. engages in the development, marketing, distribution, and sale of hemp-based consumer packaged goods and solutions in Canada and the United States. It develops and manufactures phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. The company offers pharmaceutical grade cannabinoid crystalline isolates derived from exempt parts of the hemp plant, as well as micro-encapsulations and nanotechnology for consumable and topical skin care products. It is also involved in manufacturing and distributing hemp oil and nicotine e-liquids, as well as personal care products; provision of apparel and merchandising solutions; manufactures and sells hemp infused beverages; and supplies pharmaceutical products. The company is headquartered in Vancouver, Canada.

isodiol.com

--

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

ISOLF
0.00%
S&P 500 (^GSPC)
7.42%

1-Year Return

ISOLF
0.00%
S&P 500 (^GSPC)
8.20%

3-Year Return

ISOLF
900.00%
S&P 500 (^GSPC)
68.73%

5-Year Return

ISOLF
99.50%
S&P 500 (^GSPC)
56.54%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY18
Revenue 5.89M
Earnings --
Profit Margin 0.00%

Q3

FY18

0
2M
4M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -21.95%

  • Return on Equity (ttm)

    -215.25%

  • Revenue (ttm)

    15.79M

  • Net Income Avi to Common (ttm)

    -97.76M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.51M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -26.52M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: